Nasus Pharma is trading at $3.19 (+5.28%) following a broad risk-on move in U.S. equities, as no company-specific news was identified to drive the price action.
- Broader markets are rallying, with the S&P 500 up 1.46% and the Nasdaq Composite gaining 2.11%, which typically provides a tailwind for small-cap stocks.
- Market sentiment is being bolstered by a sharp decline in oil prices and easing geopolitical tensions, supporting overall investor risk appetite.